OneLegacy Partners with OrganOx to Transform Liver Transplantation, Offering Advanced Medical Solutions to Transplant Centers in Southern California
OneLegacy is providing well-developed healthcare services to Southern California transplant centers via liver perfusion with the OrganOx metra. Normothermic machine perfusion (NMP) save significant lives by growing the number of liver transplants by 20% to 30% and lowering the transplant wait list. OneLegacy hosted an educational symposium at its Azusa Transplant Recovery Center, bringing together transplant centers and organ procurement organizations from in the country to share advance practices and explore the acceptance of the OrganOx metra and NMP technology.
"Thanks to our partnership with OrganOx, OneLegacy is offering this specialized liver perfusion center, facilitating equitable access of this technology to local transplant centers," said Prasad Garimella, CEO of OneLegacy. "By increasing the number of livers available for transplantation, we can save more lives across Southern California's diverse population."
OneLegacy is collaborating with Loma Linda University Medical Center, Keck USC Medical Center and Cedars Sinai Medical Center to offers NMP expertise and save more lives. This technology provides an advantage to both transplant centers and patients waiting for a lifesaving liver transplant, by enabling the liver to recover from physical challenges.
OrganOx metra uninterruptedly perfuses the donor liver with oxygenated blood-driven perfusate, therapeutics, and nutrients at normal body temperature and near-physiologic burdens and flows outside the body. This technology allows more up-to-date and precise assessment of livers that have otherwise been discarded to then be considered appropriate for transplantation.
"Every donated organ represents an extraordinary gift. Partnering with OneLegacy and leading transplant centers to expand access to normothermic machine perfusion reflects our shared commitment to advancing transplantation and creating more opportunities for lifesaving liver transplants," states Dr. David Reich, VP, Clinical and Medical Affairs for OrganOx.
Thanks to OrganOx's perfusion technology, OneLegacy has seen an increase of 4 percent in transplanted livers in 2025 vs. 2024. OneLegacy expects to growing the number of livers for transplantation by 14% or more in 2026.
According to Towards Healthcare, the organ donation and transplant software market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 1.66 billion in 2026 to approximately USD 4.56 billion by 2035, representing a compound annual growth rate (CAGR) of 11.9% from 2026 to 2035, driven by, it supplies patients information safely and connects medical care professionals with patients in need of organs, while adhering to administration regulations. Enhancing logistical organization and spending in advance transport infrastructure are significance steps to minimize organ wastage and confirms timely delivery.
Hasty advancement in the application of novel technologies and methods to increase organ perfusion and organ preservation during the organ donation technologies. Novel techniques and solution offers in organ donation and transplantation are decreased cold ischemic time, utilization of organs which normally discarded or not even recovered and reduces some transportation and logistics risks related with organ donation and transplantation and reducing of damage to the organs. The AI tool was intended to rationalize organ procurement via rapid verification and growing transparency in organ allocation. Confirms transparent transaction traceability to deter black-market organ interchange.
OneLegacy is the nonprofit organization intended to saving lives via organ, tissue and eye donation in seven counties in Southern California such as Los Angeles, Orange, Riverside, San Bernardino, Ventura, Santa Barbara and Kern. It provides more than 200 hospitals, transplant centers, a varied population of 20 million donors and families in the the region and waiting recipients in the country. Becoming an eye, organ or tissue donor is easy and can be done by registering online at donateLIFEcalifornia.org/OneLegacy or by "checking YES" at your local DMV. For more information, visit OneLegacy.org.
A recent report by Towards Healthcare highlights that the organ donation and transplant software market is growing as organ donation lessens the organ limitation, supports healthcare research, and lowers the challenges on the health care technology. It indorses genetic diversity for matching with a broder variety of patients and well-developed healthcare practices, advantages overall community health. Provides OPOs the interface to add, update, or delete donor data, execute match runs, and creates organ offers. Transplant hospitals application this technology to view posted donor data and record organ acceptance and refusal decisions on organ provides. Continually enhance the predictive capability of real-time, healthcare decision support tools so that it used by donation and transplant physicians to precisely detects candidates which are significant likely to be successful donors.
